Development of Novel Drugs for Alzheimer´s Disease
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 August 2020) | Viewed by 17271
Special Issue Editors
Interests: toxins; drug design and development; antidotes for pesticide and nerve agent intoxications; Alzheimer’s disease; detergents as disinfectants, decontamination means; nanotechnology; health economics and pharmacoeconomics
Special Issues, Collections and Topics in MDPI journals
2. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralové, Czech Republic
Interests: Medicinal Chemistry; Chemical and Biological Defense; Molecular Modeling; Organic Synthesis; Drug Design
Special Issues, Collections and Topics in MDPI journals
Interests: computational and medicinal chemistry; nanotechnology; solid state spectroscopy with biological and environmental interest
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is my great honor to invite you to submit your newly prepared manuscripts to our Special Issue of the MDPI journal Molecules, which is dedicated to the development of novel drugs for the treatment of Alzheimer’s disease (AD). It is known that AD represents a health, economic, and social problem that requires the full attention of scientists around the world. On the basis of this fact, every attempt to combat this disease is very important to obtain the right molecules which in the future will be considered as drug candidates for further preclinical and clinical trials. We hope that this Special Issue will encourage you to share your knowledge on this topic. In this regard, all manuscripts focusing on the design, synthesis, and in vitro and in vivo evaluation of novel AD drug candidates are welcome.
Prof. Kamil Kuča
Prof. Tanos Celmar Costa Franca
Prof. Teodorico C. Ramalho
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer’s disease
- Drug design, discovery, and development
- Drug target
- Disease treatment
- New approaches
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.